- Conflicts of interest (COI) & CRO belong to the pharmaceutical Company (CRO b2Ph wienui 2022-07-07 10:37
- Conflicts of interest (COI) & CRO belong to the pharmaceutical Company (CRO b2Ph Ohlbe 2022-07-07 10:55
- Conflicts of interest (COI) & CRO belong to the pharmaceutical Company (CRO b2Ph dshah 2022-07-07 18:52
- Conflicts of interest (COI) & CRO belong to the pharmaceutical Company (CRO b2Ph wienui 2022-07-07 20:48
- Conflicts of interest (COI) & CRO belong to the pharmaceutical Company (CRO b2Ph dshah 2022-07-08 10:23
- Conflicts of interest (COI) & CRO belong to the pharmaceutical Company (CRO b2Ph wienui 2022-07-07 20:48
- Conflicts of interest (COI) & CRO belong to the pharmaceutical Company (CRO b2Ph dshah 2022-07-07 18:52
- Conflicts of interest (COI) ElMaestro 2022-07-08 13:18
- Off topic Helmut 2022-07-08 16:29
- Off topic ElMaestro 2022-07-08 16:54
- Off topic Helmut 2022-07-08 20:41
- CRO belong to the pharmaceutical Company (CRO b2Ph wienui 2022-07-08 22:18
- CRO belong to the pharmaceutical Company (CRO b2Ph ElMaestro 2022-07-09 08:51
- CRO subsidiary of pharmaceutical company Helmut 2022-07-09 19:21
- CRO belong to the pharmaceutical Company (CRO b2Ph ElMaestro 2022-07-09 08:51
- CRO belong to the pharmaceutical Company (CRO b2Ph wienui 2022-07-08 22:18
- Off topic Helmut 2022-07-08 20:41
- Off topic ElMaestro 2022-07-08 16:54
- Off topic Helmut 2022-07-08 16:29
- Conflicts of interest (COI) & CRO belong to the pharmaceutical Company (CRO b2Ph Ohlbe 2022-07-07 10:55
- BMI Loky do 2022-06-26 17:05
- BMI in the protocol Helmut 2022-06-26 17:19
- BMI in the protocol Loky do 2022-06-29 11:11
- BMI in the protocol ElMaestro 2022-06-29 14:44
- BMI in the protocol Helmut 2022-06-26 17:19
- Unequal variances in parallel design Imph 2022-06-20 16:16
- Welch’s t-test Helmut 2022-06-20 16:47
- Welch’s t-test Imph 2022-06-23 13:02
- Welch’s t-test Helmut 2022-06-23 14:19
- Welch’s t-test Imph 2022-06-26 10:06
- Read the paper, use the code(s)! Helmut 2022-06-26 12:12
- Welch’s t-test Imph 2022-06-26 10:06
- Welch’s t-test Helmut 2022-06-23 14:19
- Welch’s t-test Imph 2022-06-23 13:02
- Welch’s t-test Helmut 2022-06-20 16:47
- Sevelamer Carbonate In vitro binding study for EMA submission jansari 2021-09-24 19:03
- Sevelamer Carbonate In vitro binding study for EMA submission jansari 2022-05-19 20:02
- Sevelamer Carbonate In vitro binding study for EMA submission dshah 2022-05-26 13:28
- Sevelamer Carbonate In vitro binding study for EMA submission jansari 2022-05-26 19:59
- Sevelamer Carbonate In vitro binding study for EMA submission dshah 2022-05-27 18:40
- Sevelamer Carbonate In vitro binding study for EMA submission jansari 2022-05-27 18:54
- Sevelamer Carbonate In vitro binding study for EMA submission dshah 2022-05-27 18:40
- Sevelamer Carbonate In vitro binding study for EMA submission jansari 2022-05-26 19:59
- Handling large Extrapolated AUC Values Sereng 2022-05-12 17:17
- residual area < 20% for more than 80% subjects mittyri 2022-05-14 22:06
- residual area < 20% for more than 80% subjects Sereng 2022-05-18 05:59
- Exclusion for the FDA? Helmut 2022-05-23 11:43
- residual area < 20% for more than 80% subjects mittyri 2022-05-14 22:06
- Bioequivalence study of sertraline HCL capsule Vishal S 2022-05-16 14:40
- Do your homework first Helmut 2022-05-16 15:48
- BE Confidence Interval Criteria: AUC(t) or AUC(inf) or both? Sereng 2022-05-12 17:14
- BE Confidence Interval Criteria: AUC(t) or AUC(inf) or both? ElMaestro 2022-05-12 22:14
- ICH guideline M10 on BA method validation PSU 2022-05-03 15:53
- Stock solutions for CCs and QCs Helmut 2022-05-04 14:48
- ICH guideline M10 on BA method validation paulhurleyuk 2022-05-05 11:47
- BE study for China jag009 2022-04-14 19:06
- Bioequivalence studies at night Loky do 2022-03-28 12:36
- Bioequivalence studies at night dshah 2022-03-28 14:23
- Kel Calculation in ANVISA Regulatory MGR 2022-03-21 07:30
- Data, please Helmut 2022-03-21 11:12
- ANVISA’s strange examples Helmut 2022-03-21 18:38
- R2adj improvement limit mittyri 2022-03-22 11:31
- R2adj improvement limit Helmut 2022-03-22 14:04
- R2adj improvement limit mittyri 2022-03-22 11:31
- Potvin method is acceptable or not for FDA khageswara Rao 2022-03-21 12:10
- Potvin method is acceptable or not for FDA ElMaestro 2022-03-21 12:37
- Simulation-based methods acceptable for the FDA Helmut 2022-03-21 13:32
- Potvin method is acceptable or not for FDA ElMaestro 2022-03-21 12:37
- Corrections for Potency Shatha 2022-03-20 14:51
- Females in Bioequivalence studies Loky do 2022-03-08 15:36
- Females in Bioequivalence studies dshah 2022-03-08 20:09
- Gender effect on metformin and sitagliptin khageswara Rao 2022-03-01 07:26
- Gender effect on metformin and sitagliptin dshah 2022-03-01 13:01
- Gender effect on metformin and sitagliptin khageswara Rao 2022-03-03 05:54
- Gender effect on metformin and sitagliptin dshah 2022-03-01 13:01